🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
63.62
-1.36 (-2.09%)
Nov 20, 2026, 4:00 PM EST - Market closed

Corcept Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
98.72120.5127.67135.5566.3377.62
Short-Term Investments
271.98251.66255.67232.67365.34145.92
Cash & Short-Term Investments
370.7372.15383.33368.22431.67223.54
Cash Growth
-12.09%-2.92%4.10%-14.70%93.11%-49.28%
Accounts Receivable
111.0659.7953.9841.1231.0627.63
Other Receivables
---1415.81.4
Receivables
111.0659.7953.9855.1246.8629.03
Inventory
11.9112.8712.417.736.14.99
Prepaid Expenses
15.2323.269.494.3214.628.92
Other Current Assets
24.9817.412.3923.24--
Total Current Assets
533.87485.46471.6458.64499.25266.46
Property, Plant & Equipment
11.466.478.010.321.781.52
Long-Term Investments
291.6160.27219.8357.184.95112.28
Long-Term Deferred Tax Assets
169.07168.2130.9190.6161.4727.46
Other Long-Term Assets
28.0216.2510.1914.7915.9916.05
Total Assets
1,034836.65840.55621.52583.43423.76

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
21.9240.4415.3817.411.986.91
Accrued Expenses
144.67117.64120.5270.4944.5239.3
Current Portion of Leases
2.021.080.830.151.140.53
Current Income Taxes Payable
---1.810.090.51
Other Current Liabilities
9.056.914.0414.6514.760.3
Total Current Liabilities
177.68166.09140.77104.5172.4947.54
Long-Term Leases
6.975.026.11---
Other Long-Term Liabilities
15.6517.7414.0810.319.10.41
Total Liabilities
200.29188.85160.96114.8181.5947.95

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.140.140.130.130.13
Additional Paid-In Capital
1,119968.6832.11738.52662.34591.35
Retained Earnings
781.39643.39543.74402.53296.39194.97
Treasury Stock
-1,066-966.59-696.17-635.08-456.15-410.41
Comprehensive Income & Other
-1.512.26-0.220.61-0.87-0.23
Shareholders' Equity
833.74647.81679.59506.71501.84375.81
Total Liabilities & Equity
1,034836.65840.55621.52583.43423.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8.996.116.940.151.140.53
Net Cash (Debt)
653.32526.32596.23425.25435.48335.29
Net Cash Growth
26.15%-11.73%40.21%-2.35%29.88%-29.32%
Net Cash Per Share
5.464.395.253.813.762.66
Filing Date Shares Outstanding
109.44106.37105.5103.52107.9105.96
Total Common Shares Outstanding
109.37105.97105.11103.41107.84105.94
Working Capital
356.2319.38330.83354.13426.76218.92
Book Value Per Share
7.626.116.474.904.653.55
Tangible Book Value
833.74647.81679.59506.71501.84375.81
Tangible Book Value Per Share
7.626.116.474.904.653.55
Machinery
-----1.16
Leasehold Improvements
-----1.26
SEC Filings: 10-K · 10-Q